Works by Jagannath, Sundar

Results: 191
    1

    Comparative effectiveness of ciltacabtagene autoleucel in CARTITUDE‐1 versus physician's choice of therapy in the Flatiron Health multiple myeloma cohort registry for the treatment of patients with relapsed or refractory multiple myeloma.

    Published in:
    EJHaem, 2022, v. 3, n. 1, p. 97, doi. 10.1002/jha2.312
    By:
    • Martin, Thomas;
    • Krishnan, Amrita;
    • Yong, Kwee;
    • Weisel, Katja;
    • Mehra, Maneesha;
    • Nair, Sandhya;
    • Qi, Keqin;
    • Londhe, Anil;
    • Diels, Joris;
    • Crivera, Concetta;
    • Jackson, Carolyn C.;
    • Olyslager, Yunsi;
    • Vogel, Martin;
    • Schecter, Jordan M.;
    • Banerjee, Arnob;
    • Valluri, Satish;
    • Usmani, Saad Z.;
    • Berdeja, Jesus G.;
    • Jagannath, Sundar
    Publication type:
    Article
    2

    Overall survival with oral selinexor plus low‐dose dexamethasone versus real‐world therapy in triple‐class‐refractory multiple myeloma.

    Published in:
    EJHaem, 2021, v. 2, n. 1, p. 48, doi. 10.1002/jha2.120
    By:
    • Richardson, Paul G.;
    • Jagannath, Sundar;
    • Chari, Ajai;
    • Vogl, Dan T.;
    • Dimopoulos, Meletios A.;
    • Moreau, Philippe;
    • Dingli, David;
    • Wei, Lee‐Jen;
    • Richter, Joshua;
    • Biran, Noa;
    • Siegel, David;
    • Reichmann, William;
    • Li, Lingling;
    • Tang, Shijie;
    • Saint‐Martin, Jean‐Richard;
    • Joshi, Anita;
    • Kauffman, Michael;
    • Shah, Jatin;
    • Shacham, Sharon;
    • Lonial, Sagar
    Publication type:
    Article
    3

    Alkaline phosphatase variation during carfilzomib treatment is associated with best response in multiple myeloma patients.

    Published in:
    European Journal of Haematology, 2011, v. 86, n. 6, p. 484, doi. 10.1111/j.1600-0609.2011.01602.x
    By:
    • Zangari, Maurizio;
    • Aujay, Monette;
    • Fenghuang Zhan;
    • Hetherington, Kristina L.;
    • Berno, Tamara;
    • Vij, Ravi;
    • Jagannath, Sundar;
    • Siegel, David;
    • Stewart, A. Keith;
    • Wang, Luhua;
    • Orlowski, Robert Z.;
    • Belch, Andrew;
    • Jakubowiak, Andrzej;
    • Somlo, George;
    • Trudel, Suzanne;
    • Bahlis, Nizar;
    • Lonial, Sagar;
    • Singhal, Seema;
    • Kukreti, Vishal;
    • Tricot, Guido
    Publication type:
    Article
    4

    The development of novel targeted therapeutics for treatment of multiple myeloma research roundtable.

    Published in:
    European Journal of Haematology, 2003, v. 70, n. 4, p. 263, doi. 10.1034/j.1600-0609.2003.t01-2-00011.x
    By:
    • Anderson, Kenneth C.;
    • Barlogie, Bart;
    • Berenson, James R.;
    • Dalton, William S.;
    • Adams, Julian;
    • Alsina, Melissa;
    • Bekker, Pirow;
    • Bergsagel, Peter L.;
    • Boise, Lawrence;
    • Chan, Kyle;
    • Chanan-Khan, Asher A.;
    • Comenzo, Raymond;
    • Congdon, Deborah;
    • Croucher, Peter;
    • Epstein, Joshua;
    • Fenton, Robert;
    • Fonseca, Rafael;
    • Gallant, Gilles;
    • Hussein, Mohamad A.;
    • Jagannath, Sundar
    Publication type:
    Article
    5
    6

    Trial designs and endpoints for immune therapies in multiple myeloma.

    Published in:
    American Journal of Hematology, 2023, v. 98, p. S35, doi. 10.1002/ajh.26753
    By:
    • Lancman, Guido;
    • Moshier, Erin;
    • Cho, Hearn Jay;
    • Parekh, Samir;
    • Richard, Shambavi;
    • Richter, Joshua;
    • Rodriguez, Cesar;
    • Rossi, Adriana;
    • Sanchez, Larysa;
    • Jagannath, Sundar;
    • Chari, Ajai
    Publication type:
    Article
    7

    Overall survival of patients with triple‐class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 1, p. E5, doi. 10.1002/ajh.26010
    By:
    • Cornell, Robert;
    • Hari, Parameswaran;
    • Tang, Shijie;
    • Biran, Noa;
    • Callander, Natalie;
    • Chari, Ajai;
    • Chhabra, Saurabh;
    • Fiala, Mark A.;
    • Gahvari, Zhubin;
    • Gandhi, Ujjawal;
    • Godby, Kelly;
    • Gupta, Ridhi;
    • Jagannath, Sundar;
    • Jagosky, Megan;
    • Kang, Yubin;
    • Kansagra, Ankit;
    • Kauffman, Michael;
    • Kodali, Saranya;
    • Kumar, Shaji K.;
    • Lakshman, Arjun
    Publication type:
    Article
    8

    Recapturing disease response: A phase 2 study of carfilzomib 56 mg/m<sup>2</sup> in patients with relapsed or refractory multiple myeloma who have progressed on carfilzomib 27 mg/m<sup>2</sup>.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 2, p. E51, doi. 10.1002/ajh.25695
    By:
    • Barley, Kevin;
    • Sanchez, Larysa;
    • Cho, Hearn J.;
    • Parekh, Samir;
    • Madduri, Deepu;
    • Richter, Joshua;
    • Isola, Luis;
    • Goldstein, Talia;
    • Dhadwal, Amishi;
    • Zarychta, Katarzyna;
    • Sanchez, Gillian Morgan;
    • Catamero, Donna;
    • Verina, Daniel;
    • Florendo, Erika;
    • Yum, Moon‐hee;
    • La, Lisa;
    • Gullie, Jude;
    • Chan, Elaine;
    • Jagannath, Sundar;
    • Chari, Ajai
    Publication type:
    Article
    9
    10
    11

    Connect MM Registry as a national reference for United States multiple myeloma patients.

    Published in:
    Cancer Medicine, 2020, v. 9, n. 1, p. 35, doi. 10.1002/cam4.2656
    By:
    • Ailawadhi, Sikander;
    • Jagannath, Sundar;
    • Narang, Mohit;
    • Rifkin, Robert M.;
    • Terebelo, Howard R.;
    • Toomey, Kathleen;
    • Durie, Brian G. M.;
    • Hardin, James W.;
    • Gasparetto, Cristina J.;
    • Wagner, Lynne;
    • Omel, James L.;
    • Kumar, Vivek;
    • Yue, Lihua;
    • Kitali, Amani;
    • Agarwal, Amit;
    • Abonour, Rafat
    Publication type:
    Article
    12
    13

    Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM Registry.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01177-6
    By:
    • Ailawadhi, Sikander;
    • Lee, Hans C.;
    • Omel, James;
    • Toomey, Kathleen;
    • Hardin, James W.;
    • Gasparetto, Cristina J.;
    • Jagannath, Sundar;
    • Rifkin, Robert M.;
    • Durie, Brian G. M.;
    • Narang, Mohit;
    • Terebelo, Howard R.;
    • Joshi, Prashant;
    • Jou, Ying-Ming;
    • Mouro, Jorge;
    • Yu, Edward;
    • Abonour, Rafat
    Publication type:
    Article
    14

    Gaps and opportunities in the treatment of relapsed-refractory multiple myeloma: Consensus recommendations of the NCI Multiple Myeloma Steering Committee.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 6, p. 1, doi. 10.1038/s41408-022-00695-5
    By:
    • Kumar, Shaji;
    • Baizer, Lawrence;
    • Callander, Natalie S.;
    • Giralt, Sergio A.;
    • Hillengass, Jens;
    • Freidlin, Boris;
    • Hoering, Antje;
    • Richardson, Paul G.;
    • Schwartz, Elena I.;
    • Reiman, Anthony;
    • Lentzsch, Suzanne;
    • McCarthy, Philip L.;
    • Jagannath, Sundar;
    • Yee, Andrew J.;
    • Little, Richard F.;
    • Raje, Noopur S.
    Publication type:
    Article
    15
    16
    17

    Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41408-020-00397-w
    By:
    • Premkumar, Vikram J.;
    • Lentzsch, Suzanne;
    • Pan, Samuel;
    • Bhutani, Divaya;
    • Richter, Joshua;
    • Jagannath, Sundar;
    • Liedtke, Michaela;
    • Jaccard, Arnaud;
    • Wechalekar, Ashutosh D.;
    • Comenzo, Raymond;
    • Sanchorawala, Vaishali;
    • Royer, Bruno;
    • Rosenzweig, Michael;
    • Valent, Jason;
    • Schönland, Stefan;
    • Fonseca, Rafael;
    • Wong, Sandy;
    • Kapoor, Prashant
    Publication type:
    Article
    18
    19
    20
    21
    22
    23

    Selinexor for the treatment of multiple myeloma.

    Published in:
    Expert Opinion on Pharmacotherapy, 2020, v. 21, n. 4, p. 399, doi. 10.1080/14656566.2019.1707184
    By:
    • Podar, Klaus;
    • Shah, Jatin;
    • Chari, Ajai;
    • Richardson, Paul G;
    • Jagannath, Sundar
    Publication type:
    Article
    24
    25

    P915: TREATMENT PATTERNS AND CLINICAL OUTCOMES OF PATIENTS WITH MULTIPLE MYELOMA PREVIOUSLY TREATED WITH LENALIDOMIDE AND AN ANTI‐CD38 MONOCLONAL ANTIBODY: FINDINGS FROM THE CONNECT MM DISEASE REGISTRY.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000970564.52503.e2
    By:
    • Abonour, Rafat;
    • Rifkin, Robert;
    • Ailawadhi, Sikander;
    • Lee, Hans C.;
    • Gasparetto, Christina;
    • Wagner, Lynne;
    • Durie, Brian;
    • Hardin, James;
    • Terebelo, Howard;
    • Narang, Mohit;
    • Toomey, Kathleen;
    • Tang, Yuexin;
    • Dhanasiri, Sujith;
    • Anand, Jasmeet;
    • Yu, Edward;
    • Marshall, Thomas;
    • Liu, Liang;
    • Jagannath, Sundar
    Publication type:
    Article
    26

    P922: ADJUSTED COMPARISONS OF CILTACABTAGENE AUTOLEUCEL WITH THERAPIES FROM REAL‐WORLD CLINICAL PRACTICE: TWO‐YEAR FOLLOW‐UP ANALYSES FROM CARTITUDE‐1 AND THE PROSPECTIVE LOCOMMOTION STUDY.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000970592.64148.2c
    By:
    • Mateos, Maria‐Victoria;
    • Weisel, Katja;
    • Martin, Tom;
    • Berdeja, Jesus;
    • Jakubowiak, Andrzej;
    • Stewart, Keith;
    • Jagannath, Sundar;
    • Lin, Yi;
    • Diels, Joris;
    • Ghilotti, Francesca;
    • Thilakarathne, Pushpike;
    • Perualila, Nolen;
    • Cabrieto, Jedelyn;
    • Erler‐Yates, Nichola;
    • Jackson, Carolyn C;
    • Schecter, Jordan;
    • Strulev, Vadim;
    • Haddad, Imene;
    • Costa Filho, Octavio;
    • Pacaud, Lida
    Publication type:
    Article
    27

    S197: LINKER‐MM1 STUDY: LINVOSELTAMAB (REGN5458) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000967700.16100.68
    By:
    • Lee, Hans C.;
    • Bumma, Naresh;
    • Richter, Joshua;
    • Dhodapkar, Madhav;
    • Hoffman, James E.;
    • Suvannasankha, Attaya;
    • Zonder, Jeffrey;
    • Shah, Mansi R.;
    • Lentzsch, Suzanne;
    • Maly, Joseph J.;
    • Ye, Jing Christine;
    • Wu, Ka Lung;
    • Deveaux, Michelle;
    • Chokshi, Dhruti;
    • Boyapati, Anita;
    • Hazra, Anasuya;
    • Lorenc, Karen Rodriguez;
    • Kroog, Glenn;
    • Houvras, Yariv;
    • Jagannath, Sundar
    Publication type:
    Article
    28

    P866: IDECABTAGENE VICLEUCEL (IDE-CEL) VS STANDARD REGIMENS IN PATIENTS WITH TRIPLE-CLASS–EXPOSED (TCE) RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM): KARMMA-3 SUBGROUP ANALYSIS BY PRIOR LINES OF THERAPY.

    Published in:
    2023
    By:
    • Manier, Salomon;
    • Rodríguez-Otero, Paula;
    • Mateos, Maria-Victoria;
    • Einsele, Hermann;
    • Bahlis, Nizar J;
    • Munshi, Nikhil;
    • Ailawadhi, Sikander;
    • Arnulf, Bertrand;
    • Nooka, Ajay;
    • Vij, Ravi;
    • Weum Abrahamsen, Ingerid;
    • Broijl, Annemiek;
    • Jagannath, Sundar;
    • Benjamin, Reuben;
    • Gergis, Usama;
    • Sborov, Douglas W.;
    • Iida, Shinsuke;
    • Truppel-Hartmann, Anna;
    • Yang, Zhihong;
    • Piasecki, Julia
    Publication type:
    Abstract
    29

    S202: CARTITUDE-1 FINAL RESULTS: PHASE 1B/2 STUDY OF CILTACABTAGENE AUTOLEUCEL IN HEAVILY PRETREATED PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA.

    Published in:
    2023
    By:
    • Munshi, Nikhil;
    • Martin, Tom;
    • Usmani, Saad Z;
    • Berdeja, Jesus;
    • Jakubowiak, Andrzej;
    • Agha, Mounzer;
    • Cohen, Adam D;
    • Deol, Abhinav;
    • Htut, Myo;
    • Lesokhin, Alexander;
    • Lin, Yi;
    • O'donnell, Elizabeth;
    • Jackson, Carolyn C;
    • Yeh, Tzu-Min;
    • Banerjee, Arnob;
    • Zudaire, Enrique;
    • Madduri, Deepu;
    • Delcorral, Christopher;
    • Pacaud, Lida;
    • Jagannath, Sundar
    Publication type:
    Abstract
    30
    31

    Pomalidomide plus low-dose dexamethasone in patients with relapsed/refractory multiple myeloma and moderate renal impairment: a pooled analysis of three clinical trials.

    Published in:
    Leukemia & Lymphoma, 2016, v. 57, n. 12, p. 2833, doi. 10.1080/10428194.2016.1177181
    By:
    • Siegel, David S.;
    • Weisel, Katja C.;
    • Dimopoulos, Meletios A.;
    • Baz, Rachid;
    • Richardson, Paul;
    • Delforge, Michel;
    • Song, Kevin W.;
    • San Miguel, Jesus F.;
    • Moreau, Philippe;
    • Goldschmidt, Hartmut;
    • Cavo, Michele;
    • Jagannath, Sundar;
    • Yu, Xin;
    • Hong, Kevin;
    • Sternas, Lars;
    • Zaki, Mohamed;
    • Palumbo, Antonio
    Publication type:
    Article
    32
    33
    34

    A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma.

    Published in:
    British Journal of Haematology, 2013, v. 161, n. 3, p. 357, doi. 10.1111/bjh.12266
    By:
    • Voorhees, Peter M.;
    • Manges, Robert F.;
    • Sonneveld, Pieter;
    • Jagannath, Sundar;
    • Somlo, George;
    • Krishnan, Amrita;
    • Lentzsch, Suzanne;
    • Frank, Richard C.;
    • Zweegman, Sonja;
    • Wijermans, Pierre W.;
    • Orlowski, Robert Z.;
    • Kranenburg, Britte;
    • Hall, Brett;
    • Casneuf, Tineke;
    • Qin, Xiang;
    • Velde, Helgi;
    • Xie, Hong;
    • Thomas, Sheeba K.
    Publication type:
    Article
    35
    36

    An open-label, single-arm, phase 2 study of single-agent carfilzomib in patients with relapsed and/or refractory multiple myeloma who have been previously treated with bortezomib.

    Published in:
    British Journal of Haematology, 2012, v. 158, n. 6, p. 739, doi. 10.1111/j.1365-2141.2012.09232.x
    By:
    • Vij, Ravi;
    • Siegel, David S.;
    • Jagannath, Sundar;
    • Jakubowiak, Andrzej J.;
    • Stewart, Alexander Keith;
    • McDonagh, Kevin;
    • Bahlis, Nizar;
    • Belch, Andrew;
    • Kunkel, Lori A.;
    • Wear, Sandra;
    • Wong, Alvin F.;
    • Wang, Michael
    Publication type:
    Article
    37
    38

    Phase 2 study of two sequential three-drug combinations containing bortezomib, cyclophosphamide and dexamethasone, followed by bortezomib, thalidomide and dexamethasone as frontline therapy for multiple myeloma.

    Published in:
    British Journal of Haematology, 2010, v. 148, n. 4, p. 562, doi. 10.1111/j.1365-2141.2009.07981.x
    By:
    • Bensinger, William I.;
    • Jagannath, Sundar;
    • Vescio, Robert;
    • Camacho, Elber;
    • Wolf, Jeffrey;
    • Irwin, David;
    • Capo, Gerardo;
    • McKinley, Marti;
    • Potts, Phyllis;
    • Vesole, David H.;
    • Mazumder, Amitabha;
    • Crowley, John;
    • Becker, Pam;
    • Hilger, Jacqueline;
    • Durie, Brian G. M.
    Publication type:
    Article
    39
    40

    Updated survival analyses after prolonged follow-up of the phase 2, multicenter CREST study of bortezomib in relapsed or refractory multiple myeloma.

    Published in:
    British Journal of Haematology, 2008, v. 143, n. 4, p. 537, doi. 10.1111/j.1365-2141.2008.07359.x
    By:
    • Jagannath, Sundar;
    • Barlogie, Bart;
    • Berenson, James R.;
    • Siegel, David S.;
    • Irwin, David;
    • Richardson, Paul G.;
    • Niesvizky, Ruben;
    • Alexanian, Raymond;
    • Limentani, Steven A.;
    • Alsina, Melissa;
    • Esseltine, Dixie-Lee;
    • Anderson, Kenneth C.
    Publication type:
    Article
    41
    42

    Long-term outcome results of the first tandem autotransplant trial for multiple myeloma.

    Published in:
    British Journal of Haematology, 2006, v. 135, n. 2, p. 158, doi. 10.1111/j.1365-2141.2006.06271.x
    By:
    • Barlogie, Bart;
    • Tricot, Guido J.;
    • van Rhee, Frits;
    • Angtuaco, Edguardo;
    • Walker, Ron;
    • Epstein, Joshua;
    • Shaughnessy, John D.;
    • Jagannath, Sundar;
    • Bolejack, Vanessa;
    • Gurley, Jennifer;
    • Hoering, Antje;
    • Vesole, David;
    • Desikan, Raman;
    • Siegel, David;
    • Mehta, Jayesh;
    • Singhal, Seema;
    • Munshi, Nikhil C.;
    • Dhodapkar, Madhav;
    • Jenkins, Bonnie;
    • Attal, Michel
    Publication type:
    Article
    43
    44

    Survival after relapse following tandem autotransplants in multiple myeloma patients: the University of Arkansas total therapy I experience.

    Published in:
    British Journal of Haematology, 2003, v. 123, n. 3, p. 484, doi. 10.1046/j.1365-2141.2003.04646.x
    By:
    • Fassas, Athansios B.-T.;
    • Barlogie, Bart;
    • Ward, Susan;
    • Jagannath, Sundar;
    • Vesole, David;
    • Mattox, Sandy;
    • Siegel, David;
    • Muwalla, Firas;
    • Zangari, Maurizio;
    • Anaissei, Elias;
    • Van Rhee, Frits;
    • Thertulien, Raymond;
    • Lee, Choon-Kee;
    • Desikan, Raman;
    • Arzumanian, Varant;
    • McCoy, Jason;
    • Tricot, Guido
    Publication type:
    Article
    45

    Infection – an underappreciated cause of bone pain in multiple myeloma.

    Published in:
    British Journal of Haematology, 2003, v. 120, n. 6, p. 1047, doi. 10.1046/j.1365-2141.2003.04178.x
    By:
    • Desikan, Raman;
    • Barlogie, Bart;
    • Sethi, Rajesh;
    • Toor, Amir;
    • Spoon, Dan;
    • Angtuaco, Edward;
    • Vanhemert, Rudy;
    • vijayaGopal, Anantha;
    • Singhal, Seema;
    • Mehta, Jayesh;
    • Jagannath, Sundar;
    • Munshi, Nikhil;
    • Zangari, Maurizio;
    • Fassas, Athanassios;
    • Tricot, Guido;
    • Anaissie, Elias
    Publication type:
    Article
    46
    47
    48
    49
    50

    Second bone marrow transplants for relapsed leukemia.

    Published in:
    1992
    By:
    • Spinolo, Jorge A.;
    • Yau, Jonathan C.;
    • Dicke, Karel A.;
    • Scott, Ellen;
    • Jagannath, Sundar;
    • Horwitz, Leonard J.;
    • Spitzer, Gary;
    • Zander, Axel R.;
    • Spinolo, J A;
    • Yau, J C;
    • Dicke, K A;
    • Scott, E;
    • Jagannath, S;
    • Horwitz, L J;
    • Spitzer, G;
    • Zander, A R
    Publication type:
    journal article